Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C O Freytes

Showing results (21-30 of 40) with videos related to

Pageof 4
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 18, 2002
Phase II study of a moderate-intensity preparative regimen with allogeneic peripheral blood stem cell transplantation for hematologic diseases: the Texas Transplant Consortium experienceP J Shaughnessy, D Ornstein, D Ririe, et al.
Journal of Hematotherapy|June 1, 1999
Successful PBSC mobilization with high-dose G-CSF for patients failing a first round of mobilizationY Gazitt, C O Freytes, N Callander, et al.
Blood|January 15, 1998
Phase I trial of a ligand fusion-protein (DAB389IL-2) in lymphomas expressing the receptor for interleukin-2C F LeMaistre, M N Saleh, T M Kuzel, et al.
Journal of the American Academy of Dermatology|July 23, 1998
Antitumor activity of DAB389IL-2 fusion toxin in mycosis fungoidesM N Saleh, C F LeMaistre, T M Kuzel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 24, 2001
Autologous transplantation for diffuse aggressive non-Hodgkin's lymphoma in patients never achieving remission: a report from the Autologous Blood and Marrow Transplant RegistryJ M Vose, M J Zhang, P A Rowlings, et al.
Bone Marrow Transplantation|May 16, 2000
Fluconazole vs low-dose amphotericin B for the prevention of fungal infections in patients undergoing bone marrow transplantation: a study of the North American Marrow Transplant GroupS N Wolff, J Fay, D Stevens, et al.
Bone Marrow Transplantation|November 26, 2013
Second transplants for multiple myeloma relapsing after a previous autotransplant-reduced-intensity allogeneic vs autologous transplantationC O Freytes, D H Vesole, J LeRademacher, et al.
Bone Marrow Transplantation|September 28, 2011
Effect of acute and chronic GVHD on relapse and survival after reduced-intensity conditioning allogeneic transplantation for myelomaO Ringdén, S Shrestha, G T da Silva, et al.
Bone Marrow Transplantation|September 18, 2002
Performance of a hybrid central venous catheter utilized for both peripheral blood stem cell harvest and transplant support of patients undergoing autologous peripheral blood stem cell transplantationA Restrepo, P Devore, C E Encarnación, et al.
Bone Marrow Transplantation|July 29, 2014
Allogeneic hematopoietic cell transplantation for mycosis fungoides and Sezary syndromeM J Lechowicz, H M Lazarus, J Carreras, et al.
Pageof 4

Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 18, 2002
Phase II study of a moderate-intensity preparative regimen with allogeneic peripheral blood stem cell transplantation for hematologic diseases: the Texas Transplant Consortium experienceP J Shaughnessy, D Ornstein, D Ririe, et al.
Journal of Hematotherapy|June 1, 1999
Successful PBSC mobilization with high-dose G-CSF for patients failing a first round of mobilizationY Gazitt, C O Freytes, N Callander, et al.
Blood|January 15, 1998
Phase I trial of a ligand fusion-protein (DAB389IL-2) in lymphomas expressing the receptor for interleukin-2C F LeMaistre, M N Saleh, T M Kuzel, et al.
Journal of the American Academy of Dermatology|July 23, 1998
Antitumor activity of DAB389IL-2 fusion toxin in mycosis fungoidesM N Saleh, C F LeMaistre, T M Kuzel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 24, 2001
Autologous transplantation for diffuse aggressive non-Hodgkin's lymphoma in patients never achieving remission: a report from the Autologous Blood and Marrow Transplant RegistryJ M Vose, M J Zhang, P A Rowlings, et al.
Bone Marrow Transplantation|May 16, 2000
Fluconazole vs low-dose amphotericin B for the prevention of fungal infections in patients undergoing bone marrow transplantation: a study of the North American Marrow Transplant GroupS N Wolff, J Fay, D Stevens, et al.
Bone Marrow Transplantation|November 26, 2013
Second transplants for multiple myeloma relapsing after a previous autotransplant-reduced-intensity allogeneic vs autologous transplantationC O Freytes, D H Vesole, J LeRademacher, et al.
Bone Marrow Transplantation|September 28, 2011
Effect of acute and chronic GVHD on relapse and survival after reduced-intensity conditioning allogeneic transplantation for myelomaO Ringdén, S Shrestha, G T da Silva, et al.
Bone Marrow Transplantation|September 18, 2002
Performance of a hybrid central venous catheter utilized for both peripheral blood stem cell harvest and transplant support of patients undergoing autologous peripheral blood stem cell transplantationA Restrepo, P Devore, C E Encarnación, et al.
Bone Marrow Transplantation|July 29, 2014
Allogeneic hematopoietic cell transplantation for mycosis fungoides and Sezary syndromeM J Lechowicz, H M Lazarus, J Carreras, et al.
Pageof 4